Now Enrolling:
Fragile X Syndrome Study (RECONNECT)

The RECONNECT study is evaluating an investigational, topical gel to address behavioural issues related to Fragile X syndrome (FXS).

The trial is currently enrolling:

  • people ages 3 to 22 with a genetic diagnosis of Fragile X syndrome
  • who are experiencing behavioural symptoms
  • and are in generally good health

Complete the form below to learn more and see if you or someone you love may be eligible to participate.

Want to Learn More? Connect With Us Today!